NCT07602270

Brief Summary

The research study is being conducted to better understand the effects of ketosis on brain functioning and the acute effects of alcohol. Participants will be asked to undergo \~4 weeks of ketogenic diet intervention. The study involves three lab visits: Lab 1 before starting the diet, Lab 2 after about 2 weeks after starting the diet, and Lab 3 after being on the diet for 4 weeks. All of the labs will include an alcohol tolerance test, and blood draws. Lab 1 and Lab 3 will also include an Magnetic resonance imaging scan. Due to scheduling, study procedures at 2 and 4 weeks may occur +/- 3 days. Magnetic resonance imaging (MRI) of the brain will measure levels of nicotinamide adenine dinucleotide (NAD) (a coenzyme that is important for energy metabolism), lactate (a metabolite produced during energy metabolism), and neurotransmitters glutamate and GABA. Alcohol tolerance will be tested using a dose of alcohol (approximately 4-5 alcohol beverages) to will elevate breath alcohol levels to approximately 0.08% to measure the acute effects of alcohol. Blood samples will be collected to measure varying metabolites.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
48mo left

Started May 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
May 2026May 2030

Study Start

First participant enrolled

May 14, 2026

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 15, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 22, 2026

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2029

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2030

Last Updated

May 22, 2026

Status Verified

May 1, 2026

Enrollment Period

3 years

First QC Date

May 15, 2026

Last Update Submit

May 15, 2026

Conditions

Keywords

Ketogenic DietAlcohol tolerance test

Outcome Measures

Primary Outcomes (1)

  • Effects of ketogenic diet on cerebral levels of glutamate.

    Glutamate levels will be measures with magnetic resonance imaging prior to and after the 4 week ketogenic diet.

    4 weeks

Secondary Outcomes (1)

  • Effects of ketogenic diet on Breath alcohol levels

    4 hours

Study Arms (1)

Ketogenic diet

EXPERIMENTAL

4 week ketogenic diet intervention

Other: Ketogenic diet

Interventions

4 week ketogenic diet

Ketogenic diet

Eligibility Criteria

Age21 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 21 years to 50 years old.
  • Willingness to provide signed, informed consent and commit to completing study procedures. Reported on at least one day in the month prior to consent of consuming 2 or more standard alcohol drinks on a single day.

You may not qualify if:

  • Unwilling or unable to refrain from use, within 24 hours of the alcohol lab procedures, psychoactive medications or medication that may affect study results.
  • Current DSM-5 diagnosis of any major psychiatric disorder (other than nicotine use disorders, or marijuana use disorders) as identified by clinical examination or structured interview that could interfere with study participation or make it hazardous for the subject.
  • Currently taking medication(s) that could interfere with study participation or make it hazardous for the subject to participate. (e.g. anticholinergics; antipsychotics; lithium; psychotropic drugs not otherwise specified)
  • A current, clinically significant physical disease or abnormality on the basis of medical history, or routine laboratory evaluation that can impact brain function, the use of a ketone supplement, administration of ketogenic diet, or the use of alcohol (e.g., epilepsy, diabetes, irritable bowel syndrome, Crohn's disease, liver disease, kidney disease, kidney stones, chronic metabolic acidosis or a cardiomyopathy as determined by history and clinical exam).
  • Currently suffering from or has a history of stroke and/or stroke related spasticity.
  • Head trauma with loss of consciousness for more than 30 minutes or associated with skull fracture, inter-cranial bleeding or abnormal MRI (self-report, medical history).
  • Weight greater than 225lbs (Need to cap amount of alcohol given based on weight to individuals).
  • Females who are pregnant or breast-feeding
  • Contraindication to MRI, including presence of ferromagnetic objects, claustrophobia or fear of enclosed, medical conditions that prevent subjects from lying comfortably flat on his/ her back for up to 2 hrs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Studies of Addiction

Philadelphia, Pennsylvania, 19104, United States

RECRUITING

MeSH Terms

Conditions

Alcohol DrinkingAlcoholismAlcoholic Intoxication

Interventions

Diet, Ketogenic

Condition Hierarchy (Ancestors)

Drinking BehaviorBehaviorAlcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Diet, Carbohydrate-RestrictedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Corinde Wiers, Ph.D.

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR
  • Henry Kranzler, MD

    University of Pennsylvania

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Open label 4 week ketogenetic diet study with alcohol tolerance tests and MRI scans
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2026

First Posted

May 22, 2026

Study Start

May 14, 2026

Primary Completion (Estimated)

May 1, 2029

Study Completion (Estimated)

May 1, 2030

Last Updated

May 22, 2026

Record last verified: 2026-05

Locations